Positive

Related by string. positive * * Rating Watch Positive . tested positive . HER2 positive breast cancer . Positive Thinking . Positive Outlook . retrieve false positives . false positives . positive vibes . Gram positive . Announces Positive . Positive Discipline . Demonstrates Positive . Positive Thinking Has Undermined . positive reinforcement . HER2 positive . estrogen receptor positive *

Related by context. All words. (Click for frequent words.) 68 Negative 67 positive 65 Postive 56 postive 56 Upbeat 54 negative 52 Negative Symptom Scale PANSS 51 POSITIVE 51 Encouraging 50 positve 49 Favorable 49 Sees Positive 49 Strong 49 Favourable 49 Positive Outlook 49 Maintains Positive 49 Supportive 48 Optimistic 48 Meets Expectations 48 Bullish 47 Cautious Optimism 47 Mixed 47 Softer 47 Muted 46 Outlook Remains 46 Critical Mass Bike Ride 46 Revises Rating Outlook 46 Draws Mixed 46 Lukewarm 46 Remains Negative 45 Diminishes 45 Revised Upward 45 Outlook Revised 45 Quantifiable 45 Remains Positive 45 Fitch Revises Rating Watch 45 Gaining Steam 45 Remains Bullish 45 Ticks Higher 45 Stronger Than Expected 44 Misys Healthcare Experience 44 Upside Surprise 44 Outside Mkts 44 Rating Outlook revision 44 Positive Outcome 44 Modest Rebound 44 Improved 44 Slowing Growth 44 Culturally Sensitive 44 Below Expectations 44 Improved Second Quarter 44 UK Claimant Count 44 Reinforce 44 Combo Therapy 44 Negative Effects 44 Gloomy Outlook 44 Committment 44 Heartening 44 Downward 44 Positivity 43 Stronger 43 Slight Improvement 43 Buying Opportunity 43 Non Negotiable 43 Leveling Off 43 Positives 43 Long Term 43 Sustained Growth 43 Translate Into 43 Better Than Expected 43 Changing Attitudes 43 Healthy Dose 43 Upturn 43 Upward Momentum 43 Idenix Pharmaceuticals Reports 43 Cautiously Optimistic 43 Exceed Estimates 43 Major Averages Remain Firmly 43 Agressive 43 Achieving Happiness 43 Stocks Wobble 43 Renewed 43 Treatment Reduces 43 Sobering 43 Trend Continues 43 Outstrips 43 Down Slightly 43 Gap Persists 43 Risk Averse 43 Higher Than Expected 43 upbeat 43 Remains Weak 43 Lupus Drug 43 Weaker Than 43 Higher Interest Rates 43 Predictive Value 43 Bearish 43 Continues Upward 43 Lower Than Expected 43 Adverse 43 Underpin 43 Weighs Heavily 43 Weaker Than Expected 43 Significantly Improved 43 Disappointing 42 Outweigh 42 Down Sharply 42 Remains Unchanged 42 Chart Presentation 42 Fitch revises 42 Downward Trend 42 GLOBAL MARKETS WEEKAHEAD 42 Remains Uncertain 42 Suppressed 42 A.M. Best Revises Outlook 42 Stronger Than Ever 42 Affordable Accessible 42 Triple Whammy 42 As Investors Await 42 Helps Lift 42 Showed Significant 42 Hepatitis C Treatment 42 Pneumonia Vaccine 42 Predict Prostate Cancer 42 Helps Improve 42 Reaps Rewards 42 Sharply Higher 42 Steadies 42 Profit Misses 42 Negatively 42 Reverses Loss 42 Downside Risks 42 Node Negative 42 Firmer 42 Choppy Trading 42 Low Probability 42 Yuan Revaluation 42 Morpace Reports 42 Nonprofit Hospitals 42 Affective 42 Doubts Linger 42 Strongly Linked 42 Flu Vaccine Shortage 42 Recession Resistant 42 Often Misdiagnosed 42 Resurging 42 Physically Fit 42 Markets Await 42 Negatively Affect 42 Range Bound 42 Remains Fragile 42 Remains Resilient 42 Helps Predict 42 Longer Term 42 Barely Changed 42 Modest 42 AARP Rother 42 May Have Peaked 42 Continue Slide 42 Success Depends 42 Gloomier 42 Trending Up 42 Results Indicate 42 Investors Await Earnings 42 Treating Depression 42 Largely Unchanged 42 Vaccine Trial 42 Delivers Strong 42 Showing Signs 42 Stays Strong 42 Stable 42 Inc. Looks Bearish 42 Worries Remain 42 Alternative Scenario 41 Smaller Than Expected 41 Critical 41 Study Shows Significant 41 Forward Looking 41 Empower Yourself 41 Orientated 41 MBS AFTERNOON 41 Positively Impacts 41 Fight Malaria 41 Upswing 41 Friendlier 41 Outlook Improves 41 Improves Quality 41 Quitting Smoking 41 Give Yourself 41 Remain Unchanged 41 Tame Inflation 41 Remain Steady 41 Its Analyst Initiation 41 Reiterate 41 Help Manage 41 Concerns Remain 41 Takes Breather 41 Fitch Revises Outlook 41 Substantial Increase 41 Differing Views 41 Shows Modest 41 Downward Pressure 41 Modest Gains 41 Image Makeover 41 BioSante Pharmaceuticals Reports 41 Accentuate 41 Exceeding Expectations 41 Renewed Commitment 41 Weak 41 Gender Differences 41 Retest 41 Yen Crosses 41 Boost Profits 41 Remain Elusive 41 Robust 41 Gives Cautious 41 Satisfactory 41 Sees Modest 41 Could Predict 41 Short Lived 41 Shows Signs 41 Hormonal Contraceptives 41 Awaits Approval 41 Inch Higher 41 Virginity Pledges 41 Testosterone Patch 41 Slowing Economy 41 Op Ed Contributors 41 Higher Margins 41 Session Lows 41 Steady 41 RealMoney Radio Mailbag 41 Traders Await 41 Remains Stable 41 Remain Strong 41 Therapy Improves 41 Awaited 41 Weakening Economy 41 Mixed Reaction 41 AIDS Epidemic 41 Negative Consequences 41 Vetterkind Cattle 41 Cautious 41 Adversely Affects 41 Inches Higher 41 Wider Than 41 Pft Taking 41 Detect Breast Cancer 41 Few Surprises 41 Shifts Toward 41 Drops Sharply 41 Slower Growth 41 Cultivates 41 Market Awaits 41 Might Affect 41 Minyan Mailbag 41 Stocks Rise Modestly 41 Moody Downgrade 41 Reaffirms Fiscal 41 Decline Sharply 41 Cites Positive 41 Dividend Payers 41 Upside Downside 41 Fullest 41 Remain Focused 41 TEXT Moody revises 41 Mixed Ahead 41 Backs FY# 41 Outweighs 41 Analyst Upgrade 41 Digging Into 41 Sucess 41 Affirms FY# 41 Says AHF 41 HBV HCV 41 Deteriorate 41 Stocks Waver 41 Subtype 41 Crisis Intensifies 41 Genes Associated 41 Forex Trading EURUSD 41 Difficult Situation 41 Recession Worries 41 Edges Lower 41 Shows Promising 41 MAIN FOCUS 41 reaffirms FY# 41 Underpins 41 Revises Second Quarter 41 Stocks Shrug Off 41 Downwards 40 Making Headway 40 Negative Feedback 40 Stages Comeback 40 Nudge Higher 40 Firmer Against 40 Negative Impact 40 RealMoney Radio Recap 40 Margin Expansion 40 Go Awry 40 Gradual Recovery 40 Wide Ranging 40 Maintains Strong 40 Investors Await 40 Slumping Economy 40 Influencing 40 Negative Symptom Scale 40 Runup 40 Its Analyst Downgrade 40 Virtually Unchanged 40 Economic Optimism 40 Overestimated 40 Guidelines Issued 40 Still Unclear 40 Sees Weak 40 Easily Accessible 40 More Susceptible 40 Promote Healthy 40 Worse Than Expected 40 Sniffing Out 40 Improved Margins 40 Improving 40 Well Positioned 40 Modest Growth 40 Bullish Sentiment 40 Reaffirms FY 40 Tops Expectations 40 Publicizes 40 Enhances Ability 40 Remain Cautious 40 Restless Legs 40 Drug Resistant Staph 40 Yen Retreats 40 Sees Gradual 40 Impairs 40 Rangebound 40 Faces Difficult 40 Detrimental 40 Start Anew 40 Stays Upbeat 40 Steady Decline 40 Boosts Profit 40 Slight Drop 40 Epithelial Cell 40 Lag Behind 40 Be Studied 40 Optimism 40 Higher Doses 40 Revises FY# 40 Failing Grades 40 Lagging Behind 40 Overly Optimistic 40 Weak Economy 40 Creeps Higher 40 Reassuring 40 Exceed Previous 40 Suffer Depression 40 Creating Meaningful 40 Helpful 40 Lowers 4Q 40 Downside Risk 40 postitive 40 Worker Shortage 40 Stagnates 40 Revises Earnings 40 Improves Outcomes 40 AIDS PLWHA 40 Interest Rate Increases 40 cent tchu ate 40 Outlook Gloomy 40 Worries Ease 40 Rating Downgrade 40 Radically Different 40 Statin Drugs 40 Options Expensing 40 Neutral Analyst Blog 40 Realistic 40 Makes Strides 40 Attained 40 Ominous Signs 40 Narrowly Mixed 40 Remain Positive 40 Divergent 40 Takeover Talk 40 Complacent 40 Interest Rate Increase 40 Slight Gains 40 Dramatically Improve 40 Positive Attitude 40 Significant 40 Double Edged Sword 40 Perform Poorly 40 Risky Behaviors 40 Faring Better Than 40 Cholesterol Drugs 40 Views Differ 40 Shrug Off 40 Cost Pressures 40 MARKET COMMENT London 40 Better Prepared 40 Realistic Expectations 40 Study Casts Doubt 40 FY Pft 40 Anemia Drug 40 Raises Hackles 40 Test Detects 40 Inching Toward 40 Econ Crisis 40 Raises Full 40 Accurately Predict 40 Formulates 40 Hormone Levels 40 Lowers Outlook 40 Report Suggests 40 Help Curb 40 Rate Climbs 40 BIG BROTHERS OF 40 Mideast Unrest 40 Face Obstacles 40 Constructive 40 Exceeded Expectations 40 Sustain Growth 40 Bodes Well 40 Bearish Trend 40 Rising Sharply 40 Positive Relationships 40 Earnings Announcements 40 Interpersonal Relationships 40 Mixed Bag 40 Pessimistic 40 Short Shrift 40 Pros Cons 40 Posts Solid 40 Must Rethink 40 Unique Challenges 40 Creep Higher 40 Volatile Trading 40 Immediately Accretive 40 Extend Rally 40 Versus Majors 40 Sour Economy 40 Genetic Predisposition 40 Bearish Sentiment 40 Stocks Fluctuate Amid 40 Monetary Easing 40 Alarming Rise 40 Shows Slight 40 Remain Stable 40 Improve Quality 40 MBS LUNCH 40 Faces Hurdles 40 Economy Grows Faster Than 40 Ratings Downgrade 40 Tight Range 40 Anti Obesity 40 Holds Gains 40 Trend Reversal 39 Swine Flu Spreads 39 Customer Responsiveness 39 Weaker 39 Guarded Optimism 39 Earnings Cheat Sheet 39 Sees Continued 39 Stocks Soar 39 Low Calorie Diet 39 Rosy Outlook 39 Underwhelming 39 Face Hurdles 39 Uphill Climb 39 Stocks Fall Sharply 39 Moderately Higher 39 Supply Constraints 39 Slight Increase 39 Step Backwards 39 Seen Steady 39 Results Confirm 39 Rises Sharply 39 Anti Angiogenesis 39 Growing Concern 39 Up Sharply 39 Raise Doubts 39 Remains Strong 39 Worth Saving 39 Empathic 39 Polls Indicate 39 Larger Than Expected 39 Outlook Brightens 39 Little Changed Ahead 39 Gathers Momentum 39 Diverge 39 Bouncing Back 39 Reiterates Sell 39 Drift Lower 39 IFMarketStrategy 39 Sector Snap Staffing 39 Cancer Diagnosis 39 Women Deserve Better 39 Sentence Sought 39 Cost Efficiencies 39 Biological Basis 39 Looks Promising 39 Muscle Wasting 39 Peer Pressure 39 Fruitful 39 Remains Cautious 39 Beats Views 39 Stocks Recover 39 Cautious Outlook 39 Legal Wrangling 39 Counteracting 39 Benefits Outweigh 39 Helps Identify 39 Seen Boosting 39 Improve Patient 39 Gets Hammered 39 Dollar Bounces 39 Multi Lingual 39 Gathers Steam 39 As Traders Await 39 Profitable Growth 39 Subdued 39 Sexually Active 39 Attractive Valuation 39 Stocks Seesaw 39 Cooler Weather 39 Erase Losses 39 Clearer Picture 39 Mad Money Mailbag 39 Stocks Surge 39 Gov't Urged 39 Abstinence Programs 39 Stocks Narrowly Mixed 39 Coronary Artery Calcium 39 Treatment Adherence 39 Remain Wary 39 Best Assigns 39 Modestly Higher 39 Bottoming Out 39 Breathing Easier 39 TheFXSpot 39 Must Adapt 39 Lose Steam 39 Higher 39 Resilient 39 Reaffirms FY# 39 Subjective 39 RPT GLOBAL MARKETS WEEKAHEAD 39 Remain Bullish 39 Transform Lives 39 Speculation Mounts 39 Trending Higher 39 Econ Recovery 39 Double Digit Revenue 39 Correlation Between 39 Purchasing Decisions 39 Acquisition Spree 39 Reap Rewards 39 Study Pinpoints 39 Growth Slowing 39 DFEL 39 Misses Q4 39 Narrow Range 39 Eagerly Awaits 39 Interest Rates Steady 39 Different Paths 39 Traveler Diarrhea 39 Potentially Fatal 39 Evolving Rating Watch 39 Offer Clues 39 Reduce Expenses 39 Lifts Restrictions 39 Shown Effective 39 Problems Linger 39 Choppy Session 39 FY# Adj 39 Investors Await Fed 39 Gonzales Resignation 39 Reaffirms Earnings 39 Trim Losses 39 Bottoming 39 Virus Infects 39 Adversely Affect 39 Earnings Soar 39 Earns Praise 39 Beats Forecasts 39 Backs FY# EPS 39 Tightening Concerns 39 Low Interest Rates 39 Drastically Cut 39 Virulent 39 Lifts FY# 39 Percent Jump 39 Substantially Reduce 39 Remains Confident 39 Global Economic Slowdown 39 Brighter Outlook 39 Aggravate 39 3Q Profit Beats 39 Gathers Pace 39 Consensus Estimates 39 Kidney Donation 39 Exerts 39 MARKET TALK NZ 39 Dollar Steady 39 XPEL Announces 39 Citi Reiterates Buy 39 Blind Eye 39 Clings To 39 Looks Toward 39 Posts Modest 39 Main Outcome Measure 39 Stresses Importance Of 39 Concerns Weigh 39 Enviable 39 Breast Cancer Treatment 39 Unexpected 39 Reaffirms Fourth Quarter 39 Uninspiring 39 Cautious Ahead 39 Up Slightly 39 ER Visits 39 Excellent 39 Stress Levels 39 Gains Update1 39 Guides FY# 39 Economists React 39 Various Types 39 Drug Resistant Tuberculosis 39 Faster Than Expected 39 Alarming 39 Significantly Improve 39 Moody Lowers 39 Risky Behavior 39 Buoyant 39 Limited Brands JC Penney 39 Prostate Cancer Vaccine 39 Self Efficacy 39 Await Word 39 Exercise Induced Asthma 39 Posts Double Digit 39 Fears Weigh 39 Tepid 39 Tricked Into 39 ERP Implementations 39 Dangerously Low 39 Have Peaked 39 Deadly Combination 39 GBP#.# Million [002] 39 Bigger Problem 39 Reprogrammed 39 Stepping Into 39 Sexual Satisfaction 39 Socioeconomic Status 39 Gaining Confidence 39 Innate 39 One Sided 39 Revised Downward 39 Exceed Expectations 39 Quantifies 39 Susceptibility Testing 39 Stocks Stabilize 39 Revenue Climbs 39 Remain Flat 39 Foreseen 39 INDEX INTELLIGENCE 39 Helps Ease 39 Being Studied 39 Data Suggest 39 Low Carbohydrate Diet 39 Prevalent 39 Raises FY# EPS 39 Beat Expectations 39 Broker Roundup 39 Urine Test 39 Sees Weaker 39 Trend Toward 39 Bullish Trend 39 Dips Slightly 39 Nutritional Status 39 Endometrial Cancer 39 Credit Card Defaults 39 Nasal Spray Vaccine 39 Help Detect 39 Budget Cuts Threaten 39 Scientists Unravel 39 Tops Views 39 Upbeat Earnings 39 Prevent Spread 39 Half Hearted 39 Vitamin D Supplementation 39 Skewed 39 Different Approach 39 Shareholders Approve Name 39 Steep Climb 39 Revises Q4 39 Unexpected Drop 39 Off Lows 39 Forging Ahead 39 Positively Impact 39 Surges Ahead 39 Improves Slightly 39 Yearend 39 End Sharply Lower 39 Virus Infection 39 Lung Cancer Survival 39 Novel Approach 39 Lowers FY# EPS 39 Dollar Recovers 39 Tumor Marker 39 Data Disappoints 39 Anxiety Depression 39 Feels Pressure 39 Highly Sensitive 39 Face Tougher 39 Amplifies 39 Embracing Change 39 Accommodative 39 Oral Fluid 39 Elicit 39 Drubbing 39 Saves Money 39 Stress Hormone 39 Sotomayor Nomination 39 Dollar Weakness 39 Says Rafidah 39 Marginally Higher 39 Urges Stronger 39 Drop Sharply 39 Remains Flat 39 Looks Bearish 39 Outlook Uncertain 39 Could Ruin 39 Folic Acid Fortification 39 Paying Dividends 39 Capitalise 39 Fluctuate 39 Sees Higher 39 Raises Hopes 39 Tick Higher 39 Attitude Toward 39 Stocks Sag 39 Panmure Gordon reiterated 39 RealMoney Radio 39 Main Outcome Measures 39 Receives Positive 39 Has Slowed 39 Overcoming Obstacles 39 Vaccine Shows Promise 39 Interest Rate Concern 39 Pares Gains 39 Profit Slips 39 Amid Weak 39 Could Complicate 39 Rejuvenates 39 Downplayed 39 Drifts Lower 39 Broken Thumb 39 Anticipates Record 39 Hindrance 39 Double Digit Gains 39 Cause Concern 39 Flu Spreads 39 Neoadjuvant Chemotherapy 39 Critical Shortage 39 Lowers 2Q 39 Helps Relieve 39 Steep Rise 39 Slips Slightly 39 Rethink 39 Volatile Session 39 Broker Downgrade 39 Lowers Q4 39 Volatile 39 Misses Forecast 39 Remain Unclear 39 Appreciable 39 Inflates 38 Inaccurate portrayals 38 Integrase Inhibitor 38 Build Momentum 38 Multiple Fronts 38 Friendliness 38 Weaker Dollar 38 Inflation Worries 38 XTENT Announces 38 Premarket 38 Energize Your 38 Revises Third Quarter 38 Validate 38 Elicits 38 Bird Flu Vaccines 38 Smoother Ride 38 Rises Slightly 38 Dragged Down 38 Right Direction 38 Successful 38 Growth Trajectory 38 Antidepressant Treatment 38 Headwind 38 Upside Potential 38 Reverses Gains 38 Session Highs 38 Distances Itself From 38 Cut Deficits 38 Actively Seeking 38 2Q Profit Drops 38 Stronger Warnings 38 Proactive Approach 38 Drug Resistant TB 38 Remain Confident 38 Liver Toxicity 38 Negative Symptoms 38 Holding Steady 38 Closely Watched 38 Receptive 38 Adtegrity.com Reports 38 Slow Start 38 Beats Expectations 38 Interest Rate Worries 38 Supply Shortage 38 Tops Q4 38 Be Short Lived 38 Reiterates FY# 38 Lay Groundwork 38 Healthbeat 38 Subtle 38 Loss Shrinks 38 Dampened 38 Unequivocal 38 Spillover 38 Shared 38 Get Screened 38 Wider Than Expected 38 Lowers 1Q 38 Protease Inhibitors 38 Deaths Prompt 38 Dip Slightly 38 Sharply Lower 38 Cause Confusion 38 Sentiment Improves 38 Counteract 38 False 38 Eke Out 38 4Q Profit Slides 38 Nudges Up 38 Considers Options 38 Political Instability 38 Oil Prices Plummet 38 Weigh Heavily 38 Sees Slight 38 PARP Inhibitor 38 Lowers Earnings 38 Hopeful Signs 38 Proactive 38 Broker snap 38 Without Sacrificing 38 Fundamentals Remain 38 Remain Above 38 Breast Tissue 38 Stocks Plummet 38 Denting 38 Gaining Strength 38 Growing Faster Than 38 Gloomy Forecast 38 Execs Say 38 Slight Gain 38 Breast Cancer Recurrence 38 Psychographic 38 Immune Cells 38 Better 38 Wary Of 38 Moral Obligation 38 Study Sheds Light 38 Stabilizes 38 4Q Profit Tops 38 Serious Threat 38 Fewer Side Effects 38 Entry Inhibitor 38 Merger Announcement 38 Below Estimates 38 Results Disappoint 38 Strengthened Balance Sheet 38 lifts FY# EPS 38 Continue Upward 38 Proactivity 38 Confirmatory 38 Pessimistic About 38 Overcome Obstacles 38 Cast Doubt 38 Made Redundant 38 Guest Satisfaction Index 38 Euro Slips 38 Shares Climb 38 #.OJ -#/# parent 38 Healthier Lifestyle 38 History Repeating Itself 38 Biased 38 False Positive 38 Outweigh Risks 38 Tapping Into 38 Supporting 38 Drug Regimen 38 Nonverbal 38 Puts Emphasis 38 Highest Ever 38 Differently Than 38 Uncovers Hidden 38 Disappoint 38 Stocks Pare Losses 38 Mixed Reactions 38 PANSS Positive 38 Debate Intensifies 38 Reports Indicate 38 Gaining Traction 38 Positive Impact 38 Posts Unexpected 38 Hematological Cancers 38 Has Silver Lining 38 Exceptional 38 Wanes 38 Liberia Poverty Reduction 38 Near Record Lows 38 Highlight Importance 38 Growing Rapidly 38 Darkens 38 Migraine Headache 38 Negatively Impact 38 Fifth Consecutive Quarter 38 Loses Steam 38 Glowing 38 Recessionary 38 Genes Linked 38 Therapy Helps 38 Conquering Cancer 38 Associated Diarrhea 38 Keeps Pressure 38 Outlook Analyst Blog 38 Delicate Balancing Act 38 Monetary Tightening 38 Misses Expectations 38 Rating Lowered 38 Preferable 38 Lowered 38 Rising Interest Rates 38 Mideast Turmoil 38 Device Helps 38 Significant Improvements 38 Draw Criticism 38 Grouped Hockey 38 Stock Plunges 38 Re Affirms 38 Focus Shifts 38 Prognostic 38 Clearer 38 Tamiflu Resistant 38 Greenhouse Gas Reductions 38 Partial Response 38 Improve Profitability 38 Rise Dramatically 38 Slower Than 38 Bright Spots 38 Bird Flu Outbreaks 38 Biggest Obstacle 38 European Forex Technicals 38 Warmer Weather 38 N.Korea Talks 38 Data Indicate 38 Expects Higher 38 Prove Effective 38 lowers FY# EPS 38 Curable 38 Disconnect Between 38 Slump Update2 38 Seasonal Flu 38 Harsh Interrogation 38 Stocks Rise Ahead 38 Severely Obese 38 Propensity 38 Precede 38 Protein Involved 38 Shootings Prompt 38 Gaining Momentum 38 Prioritized 38 Remain Mostly 38 Deteriorates 38 Subsiding 38 Posttraumatic Stress 38 Stays Positive 38 Gender Stereotypes 38 Improved Outcomes 38 Unimpressive 38 Violent Behavior 38 Brighter 38 Remain Elevated 38 Not Created Equal 38 Firming 38 Manageable 38 Bigger Than Expected 38 Uptick

Back to home page